News in the Life Sciences Industry

INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its... Read more ››

INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its... Read more ››

STOCKHOLM, Sept. 21, 2020 /PRNewswire/ -- The nomination committee of Cantargia AB (publ), comprising Sten Verland (partner in Sunstone Life Science Ventures, chairman), Jannis Kitsakis (the Fourth Swedish National Pension Fund), Alexander Mata (Alecta Pensionförsäkring, ömsesidigt) and Magnus... Read more ››

STOCKHOLM, Sept. 21, 2020 /PRNewswire/ -- The shareholders of Cantargia AB (publ) are invited to the extraordinary general meeting on Tuesday, 13 October 2020. In light of the corona virus, the meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will... Read more ››

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE... Read more ››

STOCKHOLM, Sept. 18, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) today announces that the Committee... Read more ››

LUND, Sweden, Sept. 18, 2020 /PRNewswire/ -- BrainCool AB, a Swedish medical device innovator, and a world leader... Read more ››